期刊文献+

Pin1在恶性血液病细胞和细胞周期中的表达 被引量:3

Expression of Pin1 in malignant hematopoietic cells and its relation with cell cycle
下载PDF
导出
摘要 目的 :研究 Pin1(肽酰脯胺酰顺反式易构酶 )在髓系、淋系 10种恶性血液病细胞株中的表达情况以及其与不同细胞周期的关系。方法 :利用 Realtime- PCR检测血液病细胞株的 Pin1表达 ,同时用 Thymidine和 Nocoda-zole将细胞阻断在不同的细胞周期 ,用 Realtime- PCR及 Western Blot的方法 ,检测 Pin1的 m RNA和蛋白的表达水平。结果 :Pin1在恶性血液病细胞株中 m RNA的表达明显高于正常人骨髓单个核细胞的表达 (F=10 .5 0 8,P<0 .0 1) ,其在髓系血液病细胞株和淋系恶性血液病细胞株中的表达均较正常人骨髓单个核细胞明显增高 (分别为 F= 13.5 84 ,P<0 .0 1;F=5 .339,P<0 .0 5 )。 Pin1在 G1期 m RNA的表达水平显著高于 S期 (F=4 0 .5 72 ,P<0 .0 5 ) ,S期与 M期比较没有明显差异 (F=8.30 9,P>0 .0 5 )。但在蛋白水平上来看 Pin1的变化不明显。结论 :Pin1的 m R-NA在恶性血液病细胞中呈高表达 ,其表达水平与细胞周期有关 ,其中以 G1期为最高 ,S期最低。 Objective: To study the expression of peptidyl prolyl cis/trans isomerase (PPIase or Pin1) in malignant hematopoietic cells and its relation with cell cycle. Methods: Realtime quantitative PCR with fluorescence probe hybridization was used to measure expression of Pin1 mRNA in malignant hematopoietic cell lines and normal mononuclear cells separated from bone marrow.HeLa cells were blocked with Thymidine and Nocodazole in different cell phases and then the expression of Pin1 mRNA and protein were detected by realtime PCR and immunoblotting. Results: The expression of Pin1 in malignant hematopoietic cell lines was significantly higher than that in normal controls(0 339±0 093 vs 0 038±0 005, P <0 01). Its expression in myeloid malignant hemato poietic cell lines was significantly higher than that in normal controls (0 388±0 115 vs 0 038±0 005, P <0 01) and so was the malignant lymphocytic cell lines (0 226±0 166 vs 0 038±0 005, P <0 01).The expression of Pin1 was closely correlated with cell cycle.It was the highest in G1 phase and the lowest in S phase (110 762±16 737 vs 4 080±0 634, P <0 01). Conclusion: Pin1 is overexpressed in malignant hematopoietic cell lines and its expression is different during cell cycle that is highest in G1 phase and lowest in S phase. [
出处 《浙江大学学报(医学版)》 CAS CSCD 2004年第6期500-503,514,共5页 Journal of Zhejiang University(Medical Sciences)
基金 国家重点基础研究发展计划 (973计划 )资助项目(2 0 0 2 CB71370 0 ) 国家自然科学基金资助项目 (39870 339)
关键词 白血病/病理学 基因 PIN1 细胞周期 Leukmia/pathol Pin1 Cell cycle
  • 相关文献

参考文献13

  • 1BAO L,KIMZEY A,SAUTER G,et al.Prevalent ove-rexpression of prolyl isomerase Pin1 in human cancers [J].Am J Pathol,2004,164(5):1727-1737.
  • 2LU K P,HANES S D,HUNTER T.A human peptidyl-prolyl isomerase essential for regulation of mitosis [J].Nature,1996,380(6574):544-547.
  • 3SHEN M,HAGGBLOM C,VOGT M,et al.Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis [J].Proc Natl Acad Sci U S A,1997,94(25):13618-13623.
  • 4JOSEPH J D,DAIGLE S N,MEANS A R.PINA is essential for growth and positively influences NIMA function in Aspergillus nidulans [J].J Biol Chem,2004.279(31):32373-32384.
  • 5LU K P.Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics [J].Cancer Cell,2003,4(3):175-180.
  • 6DALY N L,HOFFMANN R,OTVOS L,J R,et al.Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease [J].Biochemistry,2000,39(30):9039-9046.
  • 7GOEDERT M.Alzheimer's disease.Pinning down phosphorylated tau [J].Nature,1999,399(6738):739-740.
  • 8HAMDANE M,DELOBEL P,SAMBO A V,et al.Neurofibrillary degeneration of the Alzheimer-type:an alternate pathway to neuronal apoptosis [J].Biochem Pharmacol,2003,66(8):1619-1625.
  • 9WULF G M,LIOU Y C,RYO A,et al.Role of Pin1 in the regulation of p53 stability and p21 transactivation,and cell cycle checkpoints in response to DNA damage [J].J Biol Chem,2002,277(50):47976-47979.
  • 10ZHENG H,YOU H,ZHOU X Z,et al.The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response [J].Nature,2002,419(6909):849-853.

同被引文献43

  • 1熊文化,陈安民,郭风劲,张衣北,黄涛.PIN1反义基因转染抑制人骨肉瘤细胞的增殖[J].肿瘤,2006,26(1):32-36. 被引量:2
  • 2李红雨,徐茜,朱涛,周金华,邓东锐,王世宣,卢运萍,马丁.宫颈癌细胞株和宫颈上皮组织中Pin1和Cyclin D1的表达及临床意义[J].癌症,2006,25(3):367-372. 被引量:19
  • 3Oka T, Yoshino T, Hayashi K, et al. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias:combination analysis with cDNA expression array and tissue microarray. Am J Pathol, 2001, 159:1495-1505.
  • 4Colvin RA, Campanella GS, Sun J, et al. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem, 2004, 279: 30219-30227.
  • 5Pellegrino A, Antonaci F, Russo F, et al. CXCR3-binding chemokines in multiple myeloma. Cancer Lett, 2004, 207: 221-227.
  • 6Kitaya K, Nakayama T, Daikoku N, et al. Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium. J Clin Endocrinol Metab, 2004, 89: 2470-2476.
  • 7LaBonte ML, Choi EI, Letvin NL, et al. Molecular determinants regulating the pairing of NKG2 molecules with CD94 for cell surface heterodimer expression. J Immunol, 2004, 172 : 6902-6912.
  • 8Conejo-Garcia JR, Benencia F, Courreges MC, et al. Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells. Cancer Res,2004, 64:2175-2182.
  • 9Chen J, He Y, Simons SS Jr. Structure/activity relationships for GMEB-2: the second member of the glucocorticoid modulatory element-binding complex. Biochemistry, 2004, 43: 245-255.
  • 10Tsuruma K, Nakagawa T, Shirakum H, et al. Regulation of procaspase-2 by glucocorticoid modulatory element-binding protein 1 through the interaction with caspase recruitment domain. Biochem Biophys Res Commun, 2004, 325:1246-1251.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部